Dyne Therapeutics (DYN) Other Non-Current Assets (2019 - 2026)

Dyne Therapeutics (DYN) recorded quarterly Other Non-Current Assets of $15.6 million in Q1 2026, little changed quarter-over-quarter from $15.6 million in Q4 2025, and up 702.73% on a YoY basis from $1.9 million in Q1 2025.

Dyne Therapeutics (DYN) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Dyne Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $15.6 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 702.73% year-over-year to $15.6 million; the TTM figure through Mar 2026 stood at $15.6 million (up 702.73% YoY), while the FY2025 annual figure was $15.6 million, up 703.3% from the prior year.
  • Other Non-Current Assets was $15.6 million for Q1 2026 at Dyne Therapeutics, roughly flat from $15.6 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $15.6 million in Q4 2025 to a low of $1.9 million in Q1 2024.
  • Historically, Other Non-Current Assets has averaged $4.5 million across 5 years, with a median of $2.3 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slipped 17.28% in 2024, then surged 703.3% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.3 million in 2022, then declined by 0.17% to $2.3 million in 2023, then fell by 16.11% to $1.9 million in 2024, then soared by 703.3% to $15.6 million in 2025, then retreated by 0.07% to $15.6 million in 2026.
  • The last three Other Non-Current Assets figures came in at $15.6 million (Q1 2026), $15.6 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 60,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.26 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Dyne Therapeutics 3.00 Bn 3.00 Bn - 15.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.59 Mn
Dec 31, 2025 15.60 Mn
Sep 30, 2025 15.01 Mn
Jun 30, 2025 2.51 Mn
Mar 31, 2025 1.94 Mn
Dec 31, 2024 1.94 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 1.93 Mn
Mar 31, 2024 1.92 Mn
Dec 31, 2023 2.32 Mn
Sep 30, 2023 2.33 Mn
Jun 30, 2023 2.32 Mn
Mar 31, 2023 2.32 Mn
Dec 31, 2022 2.32 Mn
Sep 30, 2022 2.30 Mn
Jun 30, 2022 2.30 Mn
Mar 31, 2022 2.31 Mn
Dec 31, 2021 2.31 Mn
Sep 30, 2021 2.70 Mn
Jun 30, 2021 2.70 Mn